Cargando…
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
BACKGROUND: The pathogenesis of systemic sclerosis (SSc) involves a distinctive triad of autoimmune, vascular and inflammatory alterations resulting in fibrosis. Evidence suggests that peroxisome proliferator-activated receptors (PPARs) play an important role in SSc-related fibrosis and their agonis...
Autores principales: | Ruzehaji, Nadira, Frantz, Camelia, Ponsoye, Matthieu, Avouac, Jerome, Pezet, Sonia, Guilbert, Thomas, Luccarini, Jean-Michel, Broqua, Pierre, Junien, Jean-Louis, Allanore, Yannick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136696/ https://www.ncbi.nlm.nih.gov/pubmed/26961294 http://dx.doi.org/10.1136/annrheumdis-2015-208029 |
Ejemplares similares
-
The new‐generation pan‐peroxisome proliferator‐activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis
por: Wettstein, Guillaume, et al.
Publicado: (2017) -
Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018) -
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2015) -
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2023) -
Regulatory T Cells in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)